Bridging the Gap

Blog Post Image

May 17, 2023

SPARK Africa initiative launched at collaborative meeting

SPARK Africa bootcamp and conference helps progress toward an African drug research and development ecosystem

Blog Post Image

February 27, 2023

A SPARK team is developing a unique therapy for a rare disease that they think can serve as a platform

By creating a therapy for a single patient, Tom LaRocca and Matt Wheeler can generate a process for others

Blog Post Image

July 14, 2022

SPARK publishes clinical trial results of IgY antibody-based nasal drops against SARS-CoV-2

Inexpensive, safe nasal drops could be produced to combat COVID-19 and other viral pandemics

Blog Post Image

November 11, 2021

SPARK Taiwan held its annual Translational Medicine Symposium

The virtual event featured talks from Daria Mochly-Rosen and other SPARK scholars and advisors

Blog Post Image

October 4, 2021

SPARK GLOBAL holds annual meeting

SPARK GLOBAL regional representatives met virtually for the annual meeting

Blog Post Image

July 1, 2021

Natalie Torok begins NASH clinical study

SPARK Scholar investigates a repurposed drug to prevent NASH, a disease with no approved treatments

Blog Post Image

May 27, 2021

Behind the scenes of pandemic COVID-19 research

Two first-year graduate students discuss their research into SARS-CoV-2 variants

Blog Post Image

April 23, 2021

The immune system’s role in ear infection

Dr. Peter Santa Maria continues his SPARK journey to understand and treat chronic ear infection

Blog Post Image

March 24, 2021

SPARK team launches clinical COVID-19 biomarker study

SPARK staff lead an effort to characterize cardiovascular biomarkers of COVID-19 to better treat patients

Blog Post Image

February 10, 2021

SPARK advisors are one of the keys to the program’s success

Advisor participation is voluntary with no compensation. So what do advisors get out of the program? In their own words.

Blog Post Image

January 22, 2021

A neat trick – passive immunization using chicken antibodies

What is passive immunization, and why is the use of IgY antibodies from chickens in a preventative therapy so advantageous?

Blog Post Image

December 17, 2020

A blueprint for a future pandemic

Preparing for a pandemic part 2: How nasal drops are easy and inexpensive to produce worldwide

Blog Post Image

December 9, 2020

Preparing for the next pandemic

Nasal drops technology could be a blueprint to combat a future outbreak

Blog Post Image

November 24, 2020

Nasal drops with chicken antibodies to prevent COVID-19 infection

SPARK is developing a unique approach to fight coronavirus, but we need your help

Blog Post Image

October 14, 2020

Drug Discovery and its Discontents

Medicinal chemist and blogger Derek Lowe offers questions and suggestions on the state of drug discovery – how can we improve?

SPARK bridges the gap between discovery and drug treatment through a unique partnership between university and industry experts. With a modest support of $50K/year per project and comprehensive weekly coaching by over 100 volunteer experts from industry, SPARK has achieved unprecedented success in translating early academic discoveries to solutions addressing unmet needs. Want to learn more about how SPARK can help your organization? Please visit these pages for more information:

News Commercialization/Success Stories Partnering and Business Opportunities